Ocular Therapeutix Inc.
OCUL | NASDAQ
$6.91
-$0.06 (-0.86%)
Nov 2, 2026, 10:40 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 13.48M | 10.79M | 13.25M | 14.54M | 13.46M | 10.7M | 17.08M | 15.43M | 16.44M | 14.77M | 14.8M | 15.08M | 15.19M | 13.37M | 14.08M | 11.97M | 12.27M | 13.19M | 12.31M | 12.15M | 11.72M | 7.34M |
Cost of Revenue | 2.01M | 1.33M | 1.59M | 1.77M | 1.94M | 1.26M | 1.23M | 1.56M | 1.51M | 1.33M | 1.39M | 1.38M | 1.3M | 1.21M | 1.01M | 1.07M | 1.16M | 1.3M | 1.11M | 1.31M | 1.1M | 892K |
Gross Profit | 11.46M | 9.46M | 11.66M | 12.77M | 11.52M | 9.44M | 15.85M | 13.86M | 14.93M | 13.45M | 13.42M | 13.7M | 13.88M | 12.16M | 13.06M | 10.89M | 11.11M | 11.89M | 11.2M | 10.84M | 10.62M | 6.45M |
Operating Income | -82.11M | -93.34M | -69.76M | -68.7M | -67.64M | -63.92M | -50.58M | -46M | -43.59M | -31.62M | -20.05M | -19.21M | -20.57M | -22.55M | -19.36M | -21.54M | -19.92M | -17.83M | -18.05M | -19.53M | -20.23M | -20.23M |
Interest Income | 5.45M | 6.05M | 7.34M | 3.73M | 3.46M | 3.83M | 4.67M | 5.65M | 6.04M | 3.92M | 1.46M | 1.21M | 748K | 563K | 423K | 285K | 73K | 18K | 6K | 7K | 8K | 12K |
Pretax Income | -78.76M | -88.61M | -64.65M | -69.42M | -67.81M | -64.05M | -48.39M | -36.49M | -43.78M | -64.85M | -29.22M | -516K | -20.68M | -30.32M | -15.54M | -24.19M | -18.77M | -12.54M | -3.85M | 2.66M | -8.48M | 3.12M |
Net Income | -78.76M | -88.61M | -64.65M | -69.42M | -67.81M | -64.05M | -48.39M | -36.49M | -43.78M | -64.85M | -29.22M | -516K | -20.68M | -30.32M | -15.54M | -24.19M | -18.77M | -12.54M | -3.85M | 2.66M | -8.48M | 3.12M |
Selling & General & Admin | 39.44M | 36.58M | 30.62M | 29.11M | 28.08M | 30.5M | 25.44M | 22.81M | 29.67M | 24.33M | 17.27M | 17.9M | 19.36M | 19.96M | 18.88M | 18.72M | 17.93M | 16.62M | 16.67M | 17.65M | 16.99M | 15.75M |
Research & Development | 54.14M | 66.21M | 50.8M | 52.36M | 51.08M | 42.86M | 40.99M | 37.05M | 28.86M | 20.74M | 16.2M | 15.02M | 15.09M | 14.75M | 13.54M | 13.72M | 13.1M | 13.1M | 12.58M | 12.72M | 13.86M | 10.93M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 93.57M | 102.8M | 81.42M | 81.47M | 79.16M | 73.35M | 66.43M | 59.86M | 58.52M | 45.07M | 33.47M | 32.92M | 34.45M | 34.71M | 32.42M | 32.44M | 31.03M | 29.72M | 29.25M | 30.37M | 30.85M | 26.68M |
Interest Expense | 2.79M | 2.78M | 2.83M | 3M | 3.02M | 2.98M | 3.11M | 3.22M | 3.2M | 4.05M | 4.15M | 3.43M | 1.99M | 1.77M | 1.85M | 1.8M | 1.7M | 1.68M | 1.68M | 1.66M | 1.66M | 1.68M |
Selling & Marketing Expenses | 17.28M | 16.58M | 12.96M | 13.09M | 1.52M | 1.56M | 1.32M | 10.57M | 9.99M | 1.27M | -26.48M | 1.01M | 11.15M | 1.2M | 10.53M | 10.19M | 10.14M | 9.06M | 9.14M | 9.58M | 8.39M | 8.09M |
Cost & Expenses | 95.58M | 104.13M | 83.01M | 83.24M | 81.1M | 74.62M | 67.66M | 61.42M | 60.03M | 46.39M | 34.85M | 34.3M | 35.76M | 35.92M | 33.44M | 33.51M | 32.18M | 31.02M | 30.36M | 31.68M | 31.95M | 27.57M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 224.95M | 224.1M | 222.92M | 183.92M | 172.59M | 169.4M | 168.02M | 166.99M | 165.82M | 132.02M | 105.92M | 79.37M | 78.05M | 77.39M | 77.01M | 76.98M | 76.76M | 76.75M | 76.62M | 76.55M | 76.32M | 76.07M |
Shares Outstanding (Diluted) | 224.95M | 224.1M | 222.92M | 183.92M | 172.59M | 169.4M | 168.02M | 166.99M | 165.82M | 132.02M | 108.81M | 85.14M | 78.05M | 77.39M | 82.78M | 76.98M | 82.53M | 82.51M | 82.39M | 85.45M | 82.09M | 87.25M |
EPS (Basic) | -0.35 | -0.40 | -0.29 | -0.38 | -0.39 | -0.38 | -0.29 | -0.22 | -0.26 | -0.49 | -0.21 | -0.27 | -0.26 | -0.39 | -0.25 | -0.31 | -0.27 | -0.24 | -0.24 | -0.26 | -0.27 | -0.27 |
EPS (Diluted) | -0.35 | -0.40 | -0.29 | -0.38 | -0.39 | -0.38 | -0.29 | -0.22 | -0.26 | -0.49 | -0.20 | -0.25 | -0.26 | -0.39 | -0.24 | -0.31 | -0.25 | -0.22 | -0.23 | -0.23 | -0.25 | -0.24 |
EBITDA | -74.12M | -84.55M | -60.58M | -65.34M | -63.77M | -60.09M | -44.33M | -32.31M | -39.63M | -59.88M | -24.11M | 3.8M | -18.04M | -28.07M | -13.2M | -21.88M | -16.52M | -10.3M | -1.6M | 4.91M | -6.22M | 5.45M |
EBIT | -75.97M | -85.84M | -61.82M | -66.42M | -64.8M | -61.07M | -45.28M | -33.27M | -40.58M | -60.8M | -25.07M | 2.91M | -18.69M | -28.55M | -13.7M | -22.39M | -17.07M | -10.86M | -2.17M | 4.32M | -6.83M | 4.8M |
Depreciation & Amortization | 1.85M | 1.28M | 1.25M | 1.07M | 1.03M | 981K | 951K | 959K | 956K | 920K | 958K | 890K | 652K | 483K | 491K | 509K | 552K | 557K | 570K | 594K | 611K | 646K |
Add to Watchlist
Select watchlists to add or remove OCUL